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HIV-exposure, early life feeding 
practices and delivery mode 
impacts on faecal bacterial profiles 
in a South African birth cohort
Shantelle Claassen-Weitz1, Sugnet Gardner-Lubbe2, Paul Nicol3, Gerrit Botha3,  
Stephanie Mounaud4, Jyoti Shankar  4, William C Nierman4, Nicola Mulder3, Shrish Budree5,6, 
Heather J. Zar5,7,8, Mark P. Nicol1,8,9 & Mamadou Kaba1,8
There are limited data on meconium and faecal bacterial profiles from African infants and their mothers. 
We characterized faecal bacterial communities of infants and mothers participating in a South African 
birth cohort. Stool and meconium specimens were collected from 90 mothers and 107 infants at birth, 
and from a subset of 72 and 36 infants at 4–12 and 20–28 weeks of age, respectively. HIV-unexposed 
infants were primarily exclusively breastfed at 4–12 (49%, 26/53) and 20–28 weeks (62%, 16/26). In 
contrast, HIV-exposed infants were primarily exclusively formula fed at 4–12 (53%; 10/19) and 20–28 
weeks (70%, 7/10). Analysis (of the bacterial 16S rRNA gene sequences of the V4 hypervariable 
region) of the 90 mother-infant pairs showed that meconium bacterial profiles [dominated by 
Proteobacteria (89%)] were distinct from those of maternal faeces [dominated by Firmicutes (66%) 
and Actinobacteria (15%)]. Actinobacteria predominated at 4–12 (65%) and 20–28 (50%) weeks. HIV-
exposed infants had significantly higher faecal bacterial diversities at both 4–12 (p = 0.026) and 20–28 
weeks (p = 0.002). HIV-exposed infants had lower proportions of Bifidobacterium (p = 0.010) at 4–12 
weeks. Maternal faecal bacterial profiles were influenced by HIV status, feeding practices and mode of 
delivery. Further longitudinal studies are required to better understand how these variables influence 
infant and maternal faecal bacterial composition.
Early life bacterial colonization of the gastro-intestinal tract (GIT) has been reported to occur at birth1. However, 
the detection of bacteria in-utero2–6, and in the newborn’s meconium7–9, suggests foetal colonization10–12. 
Following in-utero colonization13; mode of delivery14–17, feeding practices17–19, weaning20–22, use of antibiotics23 
and latitude24,25 are all involved in shaping early life faecal bacterial profiles. Of these exposures, mode of feeding 
has been shown to greatly influence the composition, diversity and function of early life microbiota26–28, which 
persists even after the introduction of solid food28. Notably, breastfeeding has been associated with a number 
of health benefits for the infant29,30. Despite these findings, fewer HIV-infected South African women intend to 
exclusively breastfeed31, regardless of World Health Organization (WHO) recommendations in the context of 
HIV infection32.
The purpose of this study was to characterize meconium and early life faecal bacterial profiles of HIV-exposed 
and -unexposed infants enrolled in a South African birth cohort study, the Drakenstein Child Health Study 
(DCHS). To our knowledge, no studies have reported on the meconium bacterial profiles of African newborns, 
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despite African children having different GIT bacterial communities compared to those from high income 
countries33,34. We also aimed to identify key determinants of infant meconium and faecal bacterial profiles in 
HIV-exposed and -unexposed infants. We further aimed to compare infant meconium with maternal faecal bac-
terial profiles collected at the time of delivery in order to address the role of maternal GIT microbiota in in-utero 
colonization of the infant GIT in an African cohort.
Methodology
Ethics approval and consent to participate. This study (585/2015), and the DCHS (401/2009), received 
ethical approval from the Faculty of Health Sciences, Human Research Ethics Committee (HREC) of the 
University of Cape Town, South Africa. All experiments were performed in accordance with relevant guidelines 
and regulations. Mothers provided informed, written consent for enrolment of their infants at the time of delivery 
and annually.
Study participants. We investigated faecal bacterial profiles from mother-infant pairs enrolled in the 
DCHS, a birth cohort study investigating the early life determinants of child health in a peri-urban area 60 kilo-
metres from Cape Town, South Africa35. Enrolment of pregnant women took place at 20–28 weeks of gestation 
during antenatal clinic visits in two low socioeconomic communities, TC Newman (primarily a mixed ancestry 
population) and Mbekweni (primarily a black African population). The selection of participants included in this 
pilot study was based on the availability of faecal specimens from mothers and infants at the time of delivery 
and from infants at follow-up visits. The DCHS, collected faecal specimens at six-monthly intervals from all 
infants, with a convenience subset from whom faecal specimens were collected at monthly visits during the first 
year of life35. Antenatal and early life tobacco smoke exposure was measured via urine cotinine testing36 and 
HIV-exposed infants were screened for HIV infection at 6–10 weeks and at 9 months, or if clinically indicated37.
Specimen collection. Study staff collected faecal specimens (using sterile spatulas and faecal screw-cap 
containers) from mothers and infants (meconium) at birth. Faecal specimens were also collected longitudinally 
from infants during scheduled study visits35. For this study, we selected faecal specimens collected at 4 to 12 
weeks and 20 to 28 weeks of age. Intervals were selected to include the maximum number of longitudinal sample 
sets available at the time of study. In the event where meconium specimens were not collected prior to discharge, 
mothers with freezers at home were encouraged to collect and store their infants’ first faecal discharge at −20 °C. 
Transport of faecal specimens was performed under controlled conditions using ice boxes. Upon arrival at the 
laboratory, faecal specimens were stored at −80 °C until further processing.
Nucleic acid extraction. We extracted nucleic acid from faecal specimens (approximately 50 mg) using 
the QIAsymphony DSP Virus/Pathogen Mini Kit® (Qiagen GmbH, Hilden, Germany) as previously described38. 
Extracted DNA was quantified using the Qubit® 2.0 Fluorometer (InvitrogenTM, CA, USA) together with the 
Qubit™ dsDNA HS Assay Kit (InvitrogenTM, CA, USA).
16S ribosomal ribonucleic acid (rRNA) amplicon library preparation. We performed two polymer-
ase chain reactions (PCRs) using primers targeting the V4 hypervariable region of the 16S rRNA gene, with 
minor modifications39. In the first PCR reaction, we used modified-F515 (5′ - GTGCCAGCHGCYGCGGT - 3′) 
and R806 (5′ - GGACTACNNGGGTWTCTAAT - 3′ to amplify the V4 region of the bacterial 16S rRNA gene. 
The reaction consisted of 12.5 μl of 2X MyTaqTM HS Mix (Bioline, MA, USA), 2 μl forward and 2 μl reverse primer 
(each at a10 μM initial concentration), 0.75 μl of dimethyl sulfoxide (catalogue no D2650, Sigma-Aldrich®, MO, 
USA) and 4 μl template, made up to a final volume of 25.25 μl using PCR-grade water (Thermo Fisher Scientific 
Inc., MA, USA). Cycling conditions included a denaturation step at 95 °C for 3 min, an amplification step at 
95 °C for 30 sec, 50 °C for 30 sec and 72 °C for 1 sec (proceeding for 10 cycles); and a final extension step at 72 °C 
for 5 min. In the second PCR, we used 4 μl of the amplicon from the first PCR to add adapters, barcodes, 12–15 
staggered nucleotides (NNNNNNNNNNNN) and priming regions. During this second PCR, we used compos-
ite primers F515-composite (5′ - AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGC
TCTTCCGATCTNNNNNNNNNNGTGCCAGCHGCYGCGGT - 3′) and R806-composite (5′ - CAAGCAGA
AGACGGCATACGAGATACGAGACTGATTGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNN
NNNNNNNNGGACTACNNGGGTWTCTAAT - 3′) . The two-step amplification approach was performed to 
reduce the risk of non-specific binding when using adapters/sequencing primers of more than 100bp40. Staggered 
random nucleotides were incorporated to improve cluster identity and imaging in more diverse sample types40. 
Golay barcodes (12 bases underlined in the reverse primer R806-composite)39 served to multiplex samples. The 
only change made to the cycling conditions in the second PCR was the addition of 20 cycles during the amplifica-
tion step. Amplicons were cleaned using the Agencourt® AMPure® XP PCR Purification kit (Beckman Coulter, 
CA, USA). Slight modifications to the manufacturer’s protocol included the use of a 0.65:1 ratio of Agencourt 
AMPure XP solution to PCR products in step 2. PCR products were verified and annotated by agarose gel electro-
phoresis. We quantified amplicons using the Quanti-iTTM PicoGreen® dsDNA Reagent (Life Technologies, CA, 
USA) on the Infinite M1000 Pro® microplate reader (Tecan Group Ltd., Grödig, Austria) equipped with Tecan 
i-ControlTM 1.7 software. Following pooling of amplicons at 100 ng, we quantified and purified the library using 
the Nanodrop ND 1000 (Thermo Fisher Scientific Inc., MA, USA) equipped with ND-1000 3.7.1 software and 
Agencourt AMPure XP solution (at a 1:1 ratio), respectively. The pooled 16S library was excised following agarose 
gel electrophoresis, and purified using the QIAquick Gel Extraction kit (QIAgen, MA, USA). Minor modifica-
tions to the manufacturer’s protocol included incubation of the sample at 37 °C for 5 min at step 10 and heating of 
the elution buffer, Tris-EDTA buffer (pH 8.0), between 60 and 70 °C at step 13.
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16S ribosomal RNA gene sequencing. The 16S library from faecal specimens was sequenced using the 
MiSeq Reagent Kit v3, 600 cycles (Illumina, CA, USA). Sequencing controls included two Human Microbiome 
Project mock community controls (HM-782D and HM-783D) (BEI Resources, ATCC, VA, USA) and two 
no-template water controls. In addition, to serve as inter-run reproducibility measures, we randomly selected nucleic 
acid extracts from 17 faecal specimens within our cohort to be amplified and sequenced in duplicate. The KAPA 
qPCR quantification kit (KAPA Biosystems, MA, USA), as well as the Agilent DNA 1000 kit (Agilent Technologies, 
CA, USA) were used to quantify and size the library. Using these metrics, we diluted the library to 4 nM using Buffer 
EB (Qiagen, Hilden, Germany), and denaturatured and neutralized the library using 0.2 N NaOH and hybridization 
buffer (HT1). We prepared a final library dilution at 4 pM to which the internal control (15% PhiX) was added at 
4 pM. The denatured library was loaded to the Illumina® MiSeqTM platform as per manufacturer’s instructions41.
Bioinformatics pipeline. We assessed sequencing quality of FASTQ files using Fastqc42 and SolexaQA43. 
We then merged forward and reverse sequences using USEARCH7 fastq_mergepairs (fastq_maxdiffs set to 3)44, 
followed by quality filtering using USEARCH7 fastq_filter (sequences truncated to 250 and fastq_maxee set to 
0.1). Sequences from no-template water controls were aligned to biological sample sequences using USEARCH7 
usearch-global in order to remove potential contaminants. We matched each unique sequence from the two 
no-template controls to reads present in our biological samples. The average number of reads calculated from 
the two no-template controls were removed from biological samples in the event that reads matched at 100% 
similarity. USEARCH sortbysize allowed for dereplication and selection of sequences occurring more than twice. 
We clustered sequences into operational taxonomic units (OTUs) using USEARCH7 cluster_otus (with a clus-
tering radius of 3). The ChimeraSlayer reference database45 and the USEARCH7 uchime_ref tool were used to 
remove chimeras. OTU counts were obtained using USEARCH7 usearch-global. Further processing of data 
was performed using the Quantitative Insights Into Microbial Ecology (QIIME 1.7.0) suite of software tools46. 
We assigned taxonomy to representative reads, selecting SILVA47 as the reference database and a 97% sequence 
similarity, using the RDP classifier method implemented through the assign_taxonomy.py script in QIIME48. 
Sequences were aligned (align_seqs.py) at 97% similarity using the PYNAST algorithm and filtered using the 
filter_alignment.py script48.
Data availability. The raw sequence files supporting the findings of this article are available in the NCBI 
Sequence Read Archive (SRA) under the BioProject ID PRJNA356372, BioSamples SAMN06131047 to 
SAMN06131374.
Statistical analysis. We used R software version 3.1.149 together with RStudio software version 0.98.50751 
for all statistical analyses as well as graphical representations of the data. We determined the reproducibility of 
our experiment using nucleic acid extracts from 17 faecal specimens randomly selected for processing in dupli-
cate. Proportions of each OTU from each of the 17 faecal specimens were compared to the proportions from 
their technical repeats, using simple linear regression analysis to calculate the coefficient of determination (R2)50. 
We colour coded the plotted proportion of variations based on template nucleic acid concentrations, as well as 
sequencing depth.
We determined alpha and beta diversity using the Shannon diversity (H′)51,52 and the Bray Curtis dissimilarity 
index (calculated using the [vegdist] function from the R package vegan53)52,54–56, respectively. We performed 
agglomerative clustering by applying Complete Linkage (furthest neighbour) clustering using the [hclust] func-
tion in the R package stats49 together with a matrix based on the Bray-Curtis dissimilarity index. Clustering 
was performed on all OTUs with a relative abundance >0.5%. Due to the variation in the total number of reads 
sequenced across different specimens within a single run, we transformed count data57 to compositional data by 
calculating the relative abundance of each OTU per specimen58,59. As we were dealing with compositional data, 
we constructed log-ratio biplots60 using only OTUs where proportions differed significantly between participant 
groups (mothers, infants at birth, infants at 4–12 weeks and infants at 20–28 weeks) (at the 5% significance level). 
The data was adjusted in a Bayesian context to remove zeros61–63. Lambda scaling64 was employed to construct 
log-ratio biplots ensuring evenness in the spread of the modes (OTUs and specimens).
We used Fisher’s exact test for two-way tables or Pearson’s chi-square test to determine whether significant 
associations were present between covariates. We used generalized linear models (GLMs) to test the effect of 
covariates on the composition and diversity of maternal and infant faecal microbiota profiles, respectively. GLMs 
were used to test the effect of covariates at each of the time-points under study. We performed hypothesis testing 
at a 5% significance level, controlling for the false discovery rate as described by Benjamini & Hochberg65. We 
implemented the negative binomial model in RStudio66 through the family function quasipoisson; specified the 
offset as equal to “root OTU counts”67; and used paramaters estimated by the iterative weighted least squares 
method in the function [glm] in the package stats49. Final models were based on OTUs with a relative abundance 
>0.5%. These models were designed to test covariates with missing variables separately. Covariates included 
mode of delivery (vaginal delivery versus Caesarean-section delivery); gestational age; birth weight (low birth 
weight: <33 weeks gestation), birth length; gender; mode of feeding (exclusive breastfeeding, exclusive formula 
feeding or mixed feeding – a combination of breastfeeding and/or formula feeding and/or solid food); residential 
area [TC Newman (primarily a mixed ancestry population) vs. Mbekweni (primarily a black African popula-
tion)]; maternal education; maternal HIV status; maternal smoking status; maternal cotinine levels; maternal 
body mass index (BMI) at 6–10 weeks postpartum; and the number of household members. Each statistically 
significant result obtained from our GLMs was graphically investigated to eliminate spurious results. In the event 
that significant variables showed uneven data distributions, we used “refitted GLMs” to validate our findings. 
Results from GLMs on uneven data could only be reported once confirmed by refitted GLMs. Refitted GLMs 
were based on subsets of comparable data points. To confirm the effect of maternal HIV status on faecal bacterial 
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profiles, we used refitted GLMs to eliminate possible confounding effects of residential area and feeding prac-
tices. Therefore, refitted GLMs were based on data from participants residing in Mbekweni who did not practice 
exclusive formula feeding. The effect of mode of feeding on faecal bacterial profiles was confirmed by eliminating 
potential confounding effects of HIV status and residential area in the refitted GLMs. Here we only included data 
from HIV-infected mothers or HIV-exposed infants from Mbekweni. Refitted GLMs confirming the effect of 
residential area on faecal bacterial profiles included data from only HIV-uninfected mothers or HIV-unexposed 
infants which exclusively breastfed. Violin plots were used to summarise significant findings from our GLMs on 
all variables under study, including variables validated using refitted GLMs.
Differences in faecal bacterial profiles between mother-infant pairs, and amongst infants over time (using a 
subset of 36 infants with complete longitudinal data sets), were determined by generalized linear mixed models 
(GLMMs)68 using the glmmPQL function in the R package MASS69. In these models the same covariates (as 
above) were tested using GLMMs. Furthermore, these models also investigated possible interaction effects with 
each of the covariates and time (interaction-with-time models). A significant interaction effect would mean that 
the effect of the covariate differed across time-points. Significant findings from GLMs and GLMMs were also 
represented graphically; results were only deemed significant if the p-value and visual inspection of the related 
plots showed noticeable effects.
Results
Participant characteristics. Table 1 describes the characteristics of our study participants. We investigated 
the meconium bacterial profiles from 107 infants, of which the mothers of 90 infants provided a maternal faecal 
specimen at the time of delivery. Of the 107 infants investigated in this study, a subset of 72 and 36 infants had fae-
cal specimens collected at 4–12 weeks and 20–28 weeks, respectively (Supplementary Fig. S1). The median age at 
which meconium samples were collected was 12 hours (Interquartile range (IQR): 4.2–24.6) postnatally, while infant 
faecal samples were collected at median ages of seven and 24 weeks during the two longitudinal collection periods 
(Table 1). The median age of maternal participants was 25 years (Table 1). Maternal faecal specimens collected 
from mothers undergoing vaginal delivery was 0 days (IQR: 0–1). Collections from mothers undergoing Caesarean-
section deliveries took place at a median of two days after delivery (IQR: 1.5–2.5). Infants were primarily delivered 
vaginally (82%); had a median gestational age of 39 weeks; and a median birth weight of 3 kg (Table 1). We observed 
that some of our data were unevenly distributed across the groups under study (Supplementary Tables S4). Twenty 
percent of mothers were HIV-infected (18/90) (Table 1), of which the majority resided in Mbekweni (94%, 17/18) 
(Supplementary Table S1). Twenty four percent of the infants studied at birth were HIV-exposed (Table 1), but all 
were uninfected. Sixty nine percent of the HIV-exposed uninfected infants had a paired maternal sample. Most 
(85%) infants were exclusively breastfed prior to hospital discharge, while 47% and 17% were exclusively breastfed 
until 4–12 and 20–28 weeks, respectively (Table 1). All HIV-uninfected mothers exclusively breastfed prior to dis-
charge, compared to 50% (9/18) of HIV-infected mothers (Supplementary Table S1). More HIV-unexposed infants 
were exclusively breastfed compared to HIV-exposed infants at birth (99%, 76/77 vs. 42%, 11/26), at 4–12 weeks 
(49%, 26/53 vs. 37%, 7/19), and at 20–28 weeks (17%, 6/36 vs. 0%, 0/10) (Supplementary Table S1). In addition, 
fewer HIV-unexposed infants were exclusively formula fed compared to those who were HIV-exposed at birth 
(1%, 1/77 vs. 58%, 15/26), at 4–12 weeks (2%, 1/53 vs. 53%, 10/19), and at 20–28 weeks (0%, 0/26 vs 70%, 7/10) 
(Supplementary Table S1). A subset of infants also received mixed feeding (a combination of breastfeeding and/
or formula feeding and/or solid food introduction) at 4–12 weeks of age and 20–28 weeks (Table 1). Most mothers 
achieved a secondary-level of education and many were exposed to cigarette smoke (Table 1).
Meconium bacterial profiles are distinct from maternal faecal bacterial profiles at the time of delivery. 
Clustering patterns of meconium specimens did not appear to be associated with timing of specimen collec-
tion at birth (Fig. 1). When compared to maternal faecal specimens, infant meconium had significantly lower 
alpha diversity indices [Shannon-index (H′ = 2.6 (IQR = 1.9–3.1) vs. (H′ = 2.9 (IQR = 2.7–3.1); (p < 0.001)]. 
Infant meconium and maternal faecal specimens also had distinct bacterial compositions at the time of delivery 
(Supplementary Table S2). Table 2 summarises significant differences in bacterial proportions at phylum- and 
class-level observed for 90 mothers and their infants studied at the time of delivery.
Unsupervised clustering patterns at genus-level showed that maternal faecal specimens predominantly con-
tained Firmicutes and clustered together (clusters 7 and 8) (Fig. 2). Meconium specimens had high abundances 
of Proteobacteria and formed clusters 1, 2, 3, 4 and 6 (Fig. 2). Clusters no. 5 and 9 had a mix of meconium 
and maternal faecal specimens, however, no mother-infant pairs grouped within these clusters (Fig. 2). Overall, 
only two mother-infant pairs grouped closely together in clusters no. 8 (mother-infant pair no. 44) and no. 1 
(mother-infant pair no. 45) (Fig. 2A). Apart from the distinction between maternal and infant faecal bacterial 
profiles at the time of delivery, no other characteristics were associated with these profiles using unsupervised 
clustering (Fig. 2B). Similar clustering profiles were observed when each genus, irrespective of its relative abun-
dance, was treated as a single unit during unsupervised clustering (data not shown).
Changes in infant faecal bacterial profiles over the first 28 weeks of life and their correlation 
with maternal faecal specimens collected at birth. Infant meconium samples had higher alpha 
diversity measures [H′ = 2.6 (IQR = 1.9–3.1)] than infant faecal specimens collected at 4–12 weeks [H′ = 1.1 
(IQR = 0.7–1.7)] and 20–28 weeks of age [H′ = 1.5 (IQR = 1.2–1.9)] (p < 0.001). Figure 3 shows the temporal 
evolution of faecal bacterial profiles of all infants under study during the first 28 weeks of life (Supplementary 
Table S3). Meconium bacterial profiles from 107 infants at birth were distinct from bacterial profiles of faecal spec-
imens collected from the subset of infants at 4–12 weeks (n = 72) and 20–28 (n = 36) weeks of life (Fig. 3A–C). 
Maternal faecal specimens (n = 90) had a distinctly different bacterial composition when compared to infant 
meconium and faecal specimens (Fig. 3A–D).
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Log ratio biplot analysis (at genus-level) on the 36 infants with complete longitudinal sets (Fig. 4A), revealed 
similar clustering profiles as seen for the complete data set (Fig. 4B). Of note, we observed that infant faecal 
specimens sampled at 4–12 and 20–28 weeks were dominated by Lactobacillus, Streptococcus and Bifidobacterium 
and overlapped (Fig. 4A and B). Maternal faecal and infant meconium specimens collected at the time of delivery 
were distinct from each other and from infant faecal profiles at 4–12 and 20–28 weeks (Fig. 4A and B). Maternal 
faecal specimens primarily clustered around genera representing the class Clostridia. Infant meconium speci-
mens clustered around Alpha-, Beta- and Gammaproteobacteria. We also investigated whether faecal bacterial 
profiles from the three infant age groups (birth, 4–12 weeks and 20–28 weeks of life), where complete longitudinal 
sample sets were available (n = 36), were significantly different (Supplementary Table S4; Supplementary Fig. S2).
The effect of maternal HIV status, mode of feeding and residential area on faecal bacterial profiles. 
GLMs incorporating all covariates and full datasets from the groups under study showed that infant meco-
nium bacterial profiles were influenced by mode of feeding (Supplementary Fig. S3). Meconium from infants 
Characteristics
Mothers at delivery 
(n = 90)
Infants at birth 
(n = 107)
Infants at 4–12 
weeks (n = 72)
Infants at 20–28 weeks 
(n = 36)
Median (IQR) or 
N (%)
Median (IQR) or 
N (%)
Median (IQR) or 
N (%) Median (IQR) or N (%)
Age at which specimens were 
collected 25.3 (22.2–30.1) years 12.4 (4.2–24.6) hours 7 (6.5–8.5) weeks 24 (23–26) weeks
Residential area:
  TC Newman (mixed ancestry 
population) 49 (54.4%) 49 (45.8%) 30 (41.7%) 16 (44.4%)
  Mbekweni (black African 
population) 41 (45.6%) 58 (54.2%) 42 (58.3%) 20 (55.6%)
Maternal education:
  Primary level 8 (8.9%) 11 (10.3%) 8 (11.1%) 7 (19.4%)
  Secondary level 76 (84.4%) 88 (82.2%) 60 (83.3%) 26 (72.2%)
  Tertiary level 6 (6.7%) 8 (7.5%) 4 (5.6%) 3 (8.3%)
Maternal HIV status:
  HIV-infected 18 (20%) — — —
  HIV-uninfected 72 (80%) — — —
Infant HIV status:
  HIV-exposed, uninfected — 26 (24.3%) 19 (26.4%) 10 (27.8%)
  HIV-unexposed, uninfected — 81 (75.7%) 53 (73.6%) 26 (72.2%)
Maternal BMI (6–10 weeks 
postpartum) 25.8 (23.2–29.4)* 25.1 (23.0–29.1)* 25.8 (23.0–29.7)* 25.1 (22.6–29.4)*
Maternal smoking status:
  Active smoker (cotinine 
levels ≥ 500) 29 (32.2%) 31 (29.0%) 23 (31.9%) 14 (38.9%)
  Passive smoker (cotinine 
levels > 10 < 500) 39 (43.3%) 48 (44.9%) 30 (41.7%) 13 (36.1%)
  Non-smoker (cotinine 
levels ≤ 10) 22 (24.4%) 28 (26.2%) 19 (26.4%) 9 (25%)
Mode of delivery:
  Vaginal delivery 76 (84.4%) 88 (82.2%) 60 (83.3%) 29 (80.6%)
  Caesarean-section delivery 14 (15.6%) 19 (17.8%) 12 (16.7%) 7 (19.4%)
Gestational age (weeks) 39 (37.3–40) 39 (38–40) 39 (38–40) 39 (38.8–40)
Birth weight (kg) 3 (2.7–3.3) 3 (2.7–3.3) 3.1 (2.7–3.4) 3 (2.6–3.3)
Birth length (cm) 51 (48.3–52) 50 (48–53) 51 (49–53) 50.5 (49–53)
Gender:
  Male — 48 (44.9%) 33 (45.8%) 18 (50%)
Feeding:
  Exclusive breastfeeding 77 (89.5%)†⨕ 87 (84.5%)†⨕ 33 (46.5%)†,ϕ 6 (16.7%)†⤉
  Exclusive formula feeding 9 (10.5%)†⨕ 16 (15.5%)†⨕ 11 (15.5%)†,ϕ 7 (19.4%)†⤉
  Mixed feeding (breast milk, 
formula milk and/or solids) — — 27 (38%)
†,ϕ 23 (63.9%)†⤉
Household members 5 (3–6) 4 (3–6) 4 (3–6) 4 (3–6)
Table 1. Demographic and clinical characteristics of mothers and infants. *Number of observations recorded: 
Mothers at delivery: 56; Infants at birth: 69; Infants at 4–12 weeks: 53; Infants at 20–28 weeks: 27. †Number of 
observations recorded: Mothers at birth: 86; Infants at birth: 103; Infants at 4–12 weeks: 71; Infants at 20–28 
weeks: 36. ⨕Feeding recorded prior to discharge from hospital. ϕFeeding recorded at 4–12 weeks. ⤉Feeding 
recorded at 20–28 weeks. IQR: Interquartile range. HIV: Human immunodeficiency virus.
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exclusively breastfed prior to discharge (87/103) had significantly higher proportions of bacteria within the 
phyla Proteobacteria and Actinobacteria when compared to those exclusively formula fed (Supplementary 
Fig. S3; Fig. 5). Infants exclusively formula fed prior to discharge had significantly higher proportions of the fam-
ily Enterobacteriaceae (p = 0.039), including the genera Enterococcus (p = 0.002) and Streptococcus (p = 0.045) 
(Fig. 5). GLMs showed that maternal faecal bacterial profiles were significantly associated with maternal HIV 
status, mode of feeding as well as residential area (Table 3). Faecal bacterial profiles of infants at 4–12 weeks were 
also significantly associated with maternal HIV status, feeding practices and residential area (Table 3). At 20–28 
weeks, infant faecal bacterial profiles were associated with maternal HIV status and mode of feeding (Table 3).
A detailed exploratory investigation of the variables maternal HIV status, mode of feeding and residential area 
showed an uneven distribution of data across the participants under study (Supplementary Table S1). Based on 
our refitted models, used to validate the effect of these three variables, we found that only maternal HIV status 
and mode of feeding had true significant effects on maternal faecal bacterial profiles (Table 3). Infant faecal bac-
terial profiles at 4–12 and 20–28 weeks were only influenced by maternal HIV status (Table 3).
Figure 1. Log ratio biplot of infant meconium specimens, sampled during the first four days of life, in relation 
to the proportions of bacterial genera present in each of the specimens. Infant meconium specimens sampled 
during the first 24 hours of life are shown in light pink and specimens sampled between 24–48 hours, 48–72 
hours and at more than 72 hours of life are shown in darker shades of pink. Genera present at proportions 
>0.5% in meconium specimens are colour-coded according to the phylum to which they belong (Yellow: 
Actinobacteria, Green: Bacteroidetes, Red: Firmicutes, Blue: Proteobacteria). The plot simultaneously 
represents the samples and genera taking the compositional nature of sequencing data into account. Connecting 
two genera and projecting the samples onto the connecting line indicates the log ratio of abundance of the 
genera in each sample. Unique operational taxonomic unit (OTU) numbers are assigned to unclassified taxa.
Infants at birth (n = 90) 
Median (IQR)
Mothers at birth (n = 90) 
Median (IQR) p-value
Phylum Proteobacteria 88.9 (72.8–96.2) 3.2 (1.2–8.9) <0.001
  Alphaproteobacteria 7.6 (0.5–24.3) 0.1 (0.1–0.2) <0.001
  Betaproteobacteria 15.9 (0.4–25.4) 0.1 (0.1–0.2) <0.001
  Gammaproteobacteria 45.4 (10.2–75.3) 1.7 (0.8–7.4) <0.001
Phylum Firmicutes 2.2 (0.9–16.8) 66.4 (57.3–77.2) <0.001
  Bacilli 1.2 (0.5–4.6) 1.0 (0.4–2.6) 0.0001
  Clostridia 0.2 (0.1–1.7) 49.2 (38.8–61.3) <0.001
  Erysipelotrichia 0.0 (0.0–0.1) 11.1 (7.1–13.9) <0.001
Phylum Actinobacteria 4.0 (1.7–10.4) 14.5 (6.4–24.5) <0.001
  Actinobacteria 3.7 (1.6–10.2) 11.2 (3.3–21.6) <0.001
  Coriobacteriia 0.0 (0.0–0.1) 2.1 (1.4–3.3) <0.001
Phylum Bacteroidetes 0.2 (0.0–0.7) 5.0 (1.7–12.3) <0.001
  Bacteroidia 0.0 (0.0–0.1) 5.0 (1.7–12.3) <0.001
Table 2. Significant differences in bacterial proportions at phylum- and class-level observed for the 90 mother-
infant pairs studied at the time of delivery. Bacterial proportions are rounded to one decimal point. Larger 
proportions of bacterial taxa are highlighted in bold. IQR: Interquartile range.
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Maternal faecal bacterial profiles were influenced by both their HIV status and feeding practices (Table 3; 
Supplementary Figs S4 and S5). Mothers who exclusively breastfed prior to discharge (77/86) also had higher 
faecal diversity compared to mothers who exclusively formula fed [H′ = 2.9 (IQR: 2.7–3.1) vs. H′ = 2.8 (IQR: 
2.6–2.8); p = 0.034]. Infant faecal bacterial profiles at 4–12 weeks were significantly associated with maternal 
HIV status (Table 3; Supplementary Fig. S6). We found that HIV-exposed infants (19/72) had higher faecal bac-
terial diversity compared to HIV-unexposed infants (53/72) [H′ = 1.8 (IQR: 1.1–1.9) vs. H′ = 1.0 (IQR: 0.6–1.3); 
p = 0.026]. Feeding practice also significantly impacted on faecal bacterial diversities at 4–12 weeks of age. Infants 
exclusively formula fed (11/71) up to the time of sample collection had highest faecal bacterial diversity fol-
lowed by infants receiving mixed feeding (27/71) and exclusive breastfeeding (33/71) over this period (H′ = 1.9 
(IQR: 1.7–2.0) vs. H′ = 1.2 (IQR: 0.7–1.5) vs. H′ = 1.0 (IQR: 0.6–1.3); p = 0.024]. At 20–28 weeks, HIV-exposed 
infants (10/36) had significantly higher proportions of the order Bacteroidales (p = 0.030) when compared to 
HIV-unexposed infants (Table 3; Supplementary Fig. S7). Infants at 20–28 weeks also had higher faecal bacterial 
diversity [H′ = 2.0 (IQR: 1.7–2.4) vs. H′ = 1.3 (IQR: 0.9–1.7); p = 0.002].
The effect of HIV-exposure on infant faecal bacterial profiles over time was assessed using an 
interaction-with-time model. This model included complete datasets from the 36 infants with samples collected 
from birth until 20–28 weeks. We found that Proteobacteria proportions decreased with an increase in age among 
HIV-unexposed infants (Supplementary Fig. S8A). In contrast, Clostridia proportions increased with an increase 
in age among HIV-unexposed infants (Supplementary Fig. S8A). A less prominent effect of infant age on faecal 
bacterial profiles was observed among HIV-exposed infants (Supplementary Fig. S8B). Our interaction-with-time 
model also showed that infants exclusively formula fed had the highest faecal bacterial diversity measured during 
the first 28 weeks of life [birth: H′ = 1.8 (IQR: 1.7–2.4); 4–12 weeks: H′ = 1.9 (IQR: 1.7–2.0); 20–28 weeks: H′ = 2.3 
(IQR: 2.0–2.5)]. Diversity indices increased with an increase in infant age (p = 0.006). Infants who were mixed fed 
also showed a slight increase in diversity over time [4–12 weeks: H′ = 1.2 (IQR: 0.7–1.5); 20–28 weeks: H′ = 1.3 
(IQR: 1.1–1.7)]. Infants exclusively breastfed throughout the first 28 weeks of life showed a decrease in infant fae-
cal bacterial diversity as their age increased [birth: H′ = 2.7 (IQR: 2.1–3.1); 4–12 weeks: H′ = 1.0 (IQR: 0.6–1.3); 
20–28 weeks: H′ = 0.9 (IQR: 0.9–1.9)].
Figure 2. Infant and maternal faecal specimens form distinct clusters at the time of delivery, unsupervised 
clustering. (A) Dendogram representing 9 clusters for infant (n = 90) and maternal (n = 90) faecal specimens 
collected at birth. Infant faecal specimens are denoted by a “B” and maternal specimens by an “M”. Mother-
infant pairs are denoted by a unique number and colour. (B) Participant demographics including sampling 
group, mode of delivery, infant gestational age (weeks), infant birth weight (kilograms) and infant birth length 
(centimetres), gender, population group, maternal HIV (Human immunodeficiency virus) status, maternal 
education, mode of feeding at birth, maternal smoking status, maternal body mass index (BMI) at 6–10 weeks 
postpartum, maternal age (years) and number of household members. (C) Relative abundance of faecal bacteria 
at genus-level. (D) Heatmap of the relative abundance of faecal bacteria at genus-level. Unique operational 
taxonomic unit (OTU) numbers are assigned to unclassified taxa.
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Mode of delivery and its influence on infant and maternal faecal bacterial profiles. Figure 5 summa-
rises significant associations between mode of delivery and maternal faecal bacterial profiles at genus-level. Mothers 
delivering via C-section delivery (14/90) had significantly higher proportions of Escherichia-Shigella (p = 0.003), 
Figure 3. Bacterial composition of all infant and maternal faecal specimens under study. The outer ring of each 
pie chart represents the bacterial composition at phylum-level; the second ring from the outside represents the 
bacterial composition at class-level; the third ring represents the order-level and central ring of each pie chart 
represents the bacterial composition at family-level. (A) Infant meconium specimens (n = 107); (B) infant faecal 
specimens sampled at 4–12 weeks of age (n = 72); (C) infant faecal specimens sampled at 20-28 weeks of age 
(n = 36); and D) maternal faecal specimens sampled at delivery (n = 90). Unique operational taxonomic unit 
(OTU) numbers are assigned to unclassified taxa.
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Acinetobacter (p < 0.001) and Enterobacter (p = 0.03) when compared to mothers undergoing vaginal delivery 
(Supplementary Fig. S9). Higher proportions of Catenibacterium (p = 0.04), Coprococcus (p = 0.047), and Incertae 
Sedis (p = 0.01) were observed from mothers delivering via vaginal delivery. Fischer exact tests for two way tables 
showed that infant birth weight (p = 0.018), birth length (p = 0.008), as well as the period between delivery and sample 
collection (p < 0.001) were significantly associated with mode of delivery; however, none showed any direct relation-
ship with maternal faecal bacterial profiles. We further tested whether other potential confounders, such as anaemia, 
hypertension and urinary tract infections recorded during pregnancy; anaesthetic use during labour; analgesic use 
during labour; oxytocin-like substance use during labour; the period between membrane rupture and delivery; as well 
as any medication supplementation during hospitalisation, were significantly associated with delivery mode. Of these, 
only anaesthetic use during labour was significantly associated with mode of delivery (p < 0.001).
Maternal body mass index and education, infant gender, birth weight and gestational age also 
influences maternal and/or infant faecal bacterial profiles. High maternal BMI (measured at 6–10 
weeks postpartum) was associated with lower proportions of Alphaproteobacteria (RR = 0.80; p = 0.030) and 
Figure 4. Log ratio biplot of mother-infant pairs at the time of delivery, 4–12 weeks and 20–28 weeks of life in 
relation to the proportions of bacterial genera present in each of the specimen (A) Log ratio biplot of 36 mothers 
and their infants with complete longitudinal sets. (B) Log ratio biplot of 90 mothers, 107 infants sampled at the 
time of delivery, 72 infants sampled at 4–12 weeks, and 36 infants sampled at 20–28 weeks. Infant meconium 
specimens are shown yellow, infant faecal specimens sampled at 4–12 weeks of age are shown in light orange, 
infant faecal specimens sampled at 20–28 weeks of age are shown in dark orange and maternal faecal specimens 
are shown in pink. Genera present in faecal specimens with proportions >0.5% are colour-coded according 
to the phylum to which they belong (Yellow: Actinobacteria, Green: Bacteroidetes, Red: Firmicutes, Blue: 
Proteobacteria). The plot simultaneously represents the samples and genera taking the compositional nature 
of sequencing data into account. Connecting two genera and projecting the samples onto the connecting line 
indicates the log ratio of abundance of the genera in each sample. Unique operational taxonomic unit (OTU) 
numbers are assigned to unclassified taxa.
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Bacilli (RR = 0.70; p = 0.030) from meconium, whilst Gammaproteobacteria were positively correlated with 
higher maternal BMI (RR = 1.09; P = 0.024). High maternal BMI was also associated with increased propor-
tions of Veillonellaceae (RR = 1.46; p = 0.025) at 20–28 weeks of age. No correlations were observed when plot-
ting maternal BMI and Firmicutes/Bacteroidetes proportions against maternal BMI (Supplementary Fig. S10). 
Maternal education was associated with significant differences in the proportions of Gammaproteobacteria, 
Clostridia and Actinobacteria observed from maternal faecal specimens (Supplementary Fig. S11A). Maternal 
education also had a significant association with infant faecal bacterial profiles measured at 20–28 weeks of life 
(Supplementary Fig. S11B). Infant gender and birth weight was associated with faecal bacterial composition 
only at 20–28 weeks of life. Female infants had significantly higher proportions of the family Leuconostocaceae 
(p = 0.001) and the genus Weissella (p = 0.002). Infant birth weight was inversely associated with proportions of 
the families Leuconostocaceae (RR = 0.03; p < 0.001) and Ruminococcaceae (RR = 0.003; p < 0.001) as well as the 
genus Weissella (RR = 0.03; p = 0.012).
Discussion
This study is the first to investigate infant meconium bacterial profiles in an African setting. Infant meco-
nium specimens contain high abundances of the phylum Proteobacteria70,71. High proportions of the phylum 
Proteobacteria from meconium specimens in our study is in agreement with the finding by Ardissone and col-
leagues2 reporting high abundances of Proteobacteria from meconium of infants born at a gestational age of more 
than 33 weeks. Another interesting finding was the positive correlation between maternal BMI measures and the 
class Gammaproteobacteria from meconium. No differences have previously been shown between the meconium 
bacterial composition of infants born to overweight or obese (OWOB) mothers and those born to mothers with 
normal BMIs72. In contrast, differences have been reported when assessing faecal bacterial profiles collected from 
older infants72.
Infant faecal bacterial profiles have also been shown to be influenced by early life feeding practices17–19. In 
our study, the effect of mode of feeding was already evident from meconium specimens. Meconium from infants 
exclusively formula fed had significantly higher proportions of the family Enterobacteriaceae compared to those 
exclusively breastfed. Feeding has also been reported to promote shifts from the highly variable infant-like GIT 
bacterial profile towards a more stable adult-like profile when solid foods are introduced73. Primary shifts in 
infant faecal bacterial profiles during the introduction of solid foods are characterized by a significant reduction 
in Bifidobacteria20; an increase in Clostridia20 and Bacteroidetes74,75; a reduction in the proportion of facultative 
Figure 5. Covariates significantly associated with faecal bacterial genera from infant and maternal faecal 
specimens. Bacterial genera significantly associated with covariates assessed in this study are summarized. 
When comparing proportions of bacterial genera observed among categorical covariates, higher proportions 
are denoted by up arrows. Up or down arrows next to numerical covariates indicate significant associations 
observed with either an increase or decrease in the proportion of significant genera associated with these 
numerical covariates. Unique operational taxonomic unit (OTU) numbers are assigned to unclassified taxa.
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Mothers (n = 90)
Phylum Proteobacteria 0.045* 0.020* — 0.049* 0.029* —
Class Gammaproteobacteria 0.014* — — 0.031* 0.026* —
Order Enterobacteriales <0.001* — — 0.009* 0.034* —
Family Enterobacteriaceae 0.027* — 0.002* 0.009* 0.034* —
Escherichia-Shigella — — 0.040* — — —
Class Deltaproteobacteria 0.030* — — — 0.043* —
Order Desulfovibrionales 0.040* — — — 0.043* —
Family Desulfovibrionaceae 0.016* — — — 0.043* —
Class Bacilli 0.004* — — 0.002* — —
Order Lactobacillales 0.003* — — 0.003* — —
Family Streptococcaceae 0.040* — 0.004* 0.024* — —
Streptococcus — — 0.012* — — —
Family Ruminococcaceae 0.030* — — — — —
Phylum Actinobacteria — 0.020* — — 0.017* —
Class Actinobacteria — 0.030* — — 0.012* —
Order Bifidobacteriales — 0.020* — — 0.012* —
Class Coriobacteriia 0.030* — — 0.013* — —
Order Coriobacteriales 0.038* — — 0.013* — —
Family Coriobacteriaceae 0.027* — — 0.013* — —
Class Bacteroidia 0.043* — — — — —
Infants at 4–12 weeks
Phylum Proteobacteria 0.005* — — 0.043* — —
Class Gammaproteobacteria 0.006* — — 0.041* — —
Order Enterobacteriales 0.006* — — 0.041* — —
Family Enterobacteriaceae 0.007* — — 0.041* — —
Enterobacter 0.010* — — 0.036* — —
Escherichia-Shigella 0.010* — — 0.039* — —
Phylum Firmicutes — 0.011* 0.002* — — —
Class Bacilli — 0.020* 0.036* — — —
Order Lactobacillales — 0.020* 0.036* — — —
Family Leuconostocaceae — 0.001* — — — —
Weissella — 0.001* — — — —
Class Erysipelotrichia — — 0.040* — — —
Order Erysipelotrichiales — — 0.040* — — —
Class Negativicutes 0.006* — 0.036* — — —
Order Selenomonadales 0.006* — 0.036* — — —
Family Veillonellaceae 0.005* — 0.034* — — —
Phylum Actinobacteria 0.005* <0.001* — 0.047* — —
Class Actinobacteria 0.006* <0.001* — 0.045* — —
Order Bifidobacteriales 0.006* <0.001* — 0.045* — —
Family Bifidobacteriaceae 0.007* <0.001* — 0.045* — —
Bifidobacterium 0.010* — 0.045* — —
Class Coriobacteriia — 0.020* — — — —
Order Coriobacteriales — 0.020* — — — —
Family Coriobacteriaceae — 0.024* — — — —
Collinsella — 0.035* — — — —
Infants at 20–28 weeks
Class Erysipelotrichia 0.030* — — — — —
Order Erysipelotrichiales 0.030* — — — — —
Phylum Actinobacteria 0.040* 0.001* — — — 0.040*
Phylum Bacteroides 0.030* — — <0.001* — —
Class Bacteroidia 0.030* — — <0.001* — —
Order Bacteroidales 0.030* — — <0.001* — —
Table 3. Variables with uneven data distribution significantly associated with maternal and/or infant faecal 
bacterial profiles. *Significant p-values; Non-significant p-values are shown by “−”. P-values in bold highlights 
true significant results from generalised linear models (GLM)s as validated by “refitted GLMs”. HIV: Human 
immunodeficiency virus.
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anaerobes; and an increase in the overall microbial diversity20. Although we did not test the effect of solid food 
on infant faecal bacterial profiles, we did observe a slight increase in Bacteroidia and Clostridia amongst infants 
at 20–28 weeks of age.
In addition, we showed the importance of exploratory analysis in observational studies such as ours. 
Observational studies, as opposed to designed experiments, potentially allows for the investigation of uneven 
datasets and reports of spurious p-values as a result thereof. In this study, each statistically significant p-value 
was carefully investigated graphically in order to assess whether further validation of the results were needed. For 
example, one of our observations was that HIV-infected mothers primarily opted for exclusive breast- or mixed 
feeding practices whilst HIV-infected mothers tended to practice formula feeding. In our initial analysis, we found 
that both HIV-unexposed as well as breastfed infants had higher proportions of beneficial Bifidobacterium76–78. 
Upon validation of our results, we concluded that maternal HIV status was the primary driver of this observation 
among infants in our cohort. Of note, in South Africa, HIV-infected mothers tend to formula feed31 despite rec-
ommendations from the World Health Organization32. This is relevant, given the important health benefits that 
breast milk provide, including for HIV-exposed children29,30.
In this study, we also found low proportions of Bacteroidetes among our adult population contrary to previ-
ous reports79. Reduced proportions of Bacteroidetes in our cohort compared to other adult participants could be 
ascribed to the fact that we only studied faecal bacterial profiles from females. Two previous studies, one from the 
United States of America and one from four European locations (France, Germany, Italy, and Sweden), reported 
lower abundances of Bacteroidetes among adult females compared to males80,81. An alternative potential expla-
nation for the low Bacteroidetes proportions observed from our mothers may be their BMI, since the majority 
of moms participating in our study was overweight or obese. Overweight/obesity has been previously associated 
with reduced levels of Bacteroidetes and increased levels of Firmicutes82–84. The latter, however, was not observed 
in our study (Supplementary Fig. S10). In addition to the low proportions of Bacteroidetes observed from moth-
ers under study, we noted that mode of delivery influenced maternal faecal bacterial profiles. The mechanism by 
which this occurs is unknown. We hypothesize that stress may be a potential contributor to changes in maternal 
faecal bacterial profiles during delivery. Studies have shown that stress may alter the maternal GIT85 and vag-
inal microbiota85,86. In addition, it has been reported that maternal prenatal stress may contribute to shifts in 
infant faecal bacterial profiles87. We also thought of investigating the effect of the process of delivery, in particular 
anaesthetic use during delivery, on maternal faecal bacterial profiles. Although we found a significant association 
between mode of delivery and anaesthetic use, we could not establish whether the use of anaesthetics or some 
other aspect of Caesarean-section delivery caused these changes. This was primarily due to the fact that anaes-
thetics were given to all mothers undergoing Caesarean-section delivery. In support of the hypothesis that mode 
of delivery may modulate maternal faecal microbiota profiles, previous reports have shown some influence on 
maternal colostrum and breastmilk as well as vaginal bacterial profiles88–91. We further found that feeding prac-
tices had a significant effect on maternal faecal bacterial profiles. This is surprising given the short time-frame 
between the birth process and specimen collection from mothers. The bacterial entero-mammary pathway92 
could potentially support this finding due to the potential crosstalk between the maternal GIT and mammary 
glands. Nevertheless, further investigation is needed to support our finding.
Limitations
In this study, one of the main limitations was the drop in the number of infants assessed at follow-up time-points. 
Among the 107 infants studied at birth, only 36 were followed longitudinally up until 20–28 weeks. Missed sam-
ples were primarily due to the inability of infants to pass stool at the scheduled study visits. In addition, some 
infants could not attend the scheduled stool sample collection visit. Hence, significant findings from the reduced 
sample size of 36 assessed at 20–28 weeks of life may need to be interpreted with caution due to the variable 
nature of the faecal microbiota composition. However consistencies of results across age groups in our analysis 
provide confidence that significant effects displayed by our data are indeed true effects. Another potential limi-
tation of this study might be the sequencing depths obtained for faecal specimens under investigation as previ-
ously highlighted by Ni and colleagues93. However, we are confident that the sequencing depth obtained in our 
study was sufficient to answer our research questions (Supplementary Fig. S12)93,94. We did not observe any effect 
of sequencing depth on the clustering profiles observed for the different groups under study (Supplementary 
Fig. S13). In contrast, we noted that template concentration had a bigger effect on reproducibility compared to 
sequencing depth (Supplementary Fig. S14).
Conclusion
The meconium from infants investigated in our study contained high proportions of the phylum Proteobacteria, 
in particular bacteria within the Enterobacteriaceae family. Infant meconium was distinct from maternal fae-
cal bacterial profiles sampled at birth. In addition, infant faecal bacterial profiles changed during the first 28 
weeks of life. Major determinants of infant meconium bacterial profiles were mode of feeding and maternal BMI. 
HIV-exposure, on the other hand, was an important contributor to the composition of infant faecal bacterial 
profiles at 4–12 weeks of life, with HIV-exposed infants having higher bacterial diversity and reduced propor-
tions of Bifidobacteria. Maternal faecal bacterial profiles following delivery were also influenced by their HIV 
status, feeding practices, as well as mode of delivery. Further large longitudinal studies are needed to improve 
our understanding of the contribution of maternal HIV status and mode of delivery to infant and maternal faecal 
microbial profiles.
Summary of 16S rRNA sequencing data output and reproducibility. Following the removal 
of potential contaminating reads we obtain a median of 5465 (IQR: 3159–9877) post-filtered reads per sam-
ple. Maternal faecal specimens sampled at birth had the lowest number of reads following correction for 
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contamination (median: 3155; IQR: 2104–4355); followed by infants at 20–28 weeks (median: 5636; IQR: 4228–
7084) and infants at 4–12 weeks (median: 6407; IQR: 4069–9042). Infants at birth had the highest number of 
reads sequenced from their meconium (median: 10002; IQR: 5065–14830). Rarefaction curve analysis indicates 
sufficient sequences for calculating Shannon diversity indices in our study (Supplementary Fig. S12).
According to Ni and colleagues, a decrease in sequencing depth results in an increase in dissimilarities (beta 
diversities) between microbial community samples93. Multidimensional scaling95 showed an effect of sequencing 
depth on dissimilarity indices (beta diversities)54,55 between samples in our study. Samples with low sequencing 
depths (in red) had higher beta diversities compared to samples with higher sequencing depths (in green and 
blue) (Supplementary Fig. S13A). Although we observed an effect of sequencing depth on beta diversities, this 
did not have a large enough influence to impact on beta diversities calculated between different sampling groups 
(Supplementary Fig. S13B). We observed distinct clusters between maternal faecal specimens; infant meconium 
specimens; and infant faecal specimens collected at 4–12 and 20–28 weeks of age, which corresponds to our log 
ratio biplot analysis (Fig. 4).
The subset of faecal specimens (n = 17) that were processed in duplicate confirms that our 16S rRNA sequenc-
ing technique was reproducible (adjusted R2 = 0.98). However, we determined that sequencing data was less 
reproducible where lower template concentrations used during library preparation (Supplementary Fig. S14A), 
as previously reported96. Of note, template concentration seemed to have a more pronounced effect on reproduci-
bility compared to sequencing depth (Supplementary Fig. S14B). Mock communities (HM782-D and HM783-D) 
(BEI Resources, ATCC, VA, USA) were sequenced successfully with similar profiles generated as previously 
reported when targeting the V4 hypervariable region of the 16S rRNA gene97.
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